MedTrace Logo

Reducing Delay of Vaccination in Children Study

NCT02665013 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 824

Last updated 2019-06-13

No results posted yet for this study

Summary

This trial will assess the effectiveness of a tailored message intervention on decreasing infant undervaccination.

Conditions

  • Communicable Diseases

Interventions

BEHAVIORAL

Tailored

Pregnant women will be recruited to the study. The intervention will be delivered to participants prior to the child's 2 month well child visit, when the child is between 4 and 6 months of age, and when the child is 10-12 months of age. The first intervention occurs at enrollment in the study. Participants in the tailored intervention arm will receive vaccine information tailored specific to her concerns and values at each intervention point.

BEHAVIORAL

Untailored

Pregnant women will be recruited to the study. The intervention will be delivered to participants prior to the child's 2 month well child visit, when the child is between 4 and 6 months of age, and when the child is 10-12 months of age. The first intervention occurs at enrollment in the study. Participants in the untailored arm will receive vaccine information at each intervention time point, but it will not be tailored to her specific concerns.

Sponsors & Collaborators

  • University of Colorado, Denver

    collaborator OTHER

  • University of Michigan

    collaborator OTHER

  • Kaiser Permanente

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02665013 on ClinicalTrials.gov